0001493152-21-005913.txt : 20210312
0001493152-21-005913.hdr.sgml : 20210312
20210312165758
ACCESSION NUMBER: 0001493152-21-005913
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210310
FILED AS OF DATE: 20210312
DATE AS OF CHANGE: 20210312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freeburg Thomas John
CENTRAL INDEX KEY: 0001736975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24249
FILM NUMBER: 21738281
MAIL ADDRESS:
STREET 1: INTERPACE DIAGNOSTICS GROUP, INC.
STREET 2: 300 INTERPACE PKWY, BLDG. C
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERPACE BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001054102
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 222919486
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: MORRIS CORPORATE CENTER 1,
STREET 2: BUILDING C, 300 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 412-224-6100
MAIL ADDRESS:
STREET 1: MORRIS CORPORATE CENTER 1,
STREET 2: BUILDING C, 300 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: Interpace Diagnostics Group, Inc.
DATE OF NAME CHANGE: 20151223
FORMER COMPANY:
FORMER CONFORMED NAME: PDI INC
DATE OF NAME CHANGE: 20021113
FORMER COMPANY:
FORMER CONFORMED NAME: PROFESSIONAL DETAILING INC
DATE OF NAME CHANGE: 19980129
4
1
ownership.xml
X0306
4
2021-03-10
0
0001054102
INTERPACE BIOSCIENCES, INC.
IDGX
0001736975
Freeburg Thomas John
INTERPACE BIOSCIENCES, INC
300 INTERPACE PARKWAY
PARSIPPANY
NJ
07054
0
1
0
0
Chief Financial Officer
Common Stock
2021-03-10
4
A
0
50000
A
52000
D
Stock Option (right to buy)
6.00
2021-03-10
4
A
0
50000
0
A
2031-03-10
Common Stock
50000
50000
D
The restricted stock units vest annually, in equal installments, over a three-year period, commencing on March 10, 2021.
Each restricted stock unit represents the contingent right to receive one share of common stock of the Issuer.
The stock options vest and become exercisable over a three-year period, in equal installments, commencing on March 10, 2021, subject to the reporting person's continued service with the Issuer.
/s/ Thomas John Freeburg
2021-03-12